Vertex Pharma Obtains Exclusive License To TreeFrog’s Cell Manufacturing Technology, C-Stem
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that it has obtained an exclusive license from TreeFrog Therapeutics, a French-based biotech company, to its proprietary cell manufacturing technology, C-Stem, to optimize production of Vertex’s cell therapies for t
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1092093268-80a57498263449618de3d6c9ae9421cb.jpg "When Is It a Good Idea to Use ILIT Trust?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1978625622-8f9bb3f8e3b045c1b960921e5482ebea.jpg "How to Start Saving for a House")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-14922896821-6ef015efaf9b49dea9a6603ee12494f1.jpg "New Year, New Wealth: 5 Strategic Resolutions Every Investor Should Follow")
:max_bytes(150000):strip_icc():format(jpeg)/business-woman-thinking-account-923217650-ded5ea97791f4fd5a908a650af38b236.jpg "How to Calculate a Discount Rate in Excel")